in

Pfizer cuts earnings outlook on lower COVID-19 drug sales

pfizer

Credit: Unsplash/CC0 Public Domain

The US pharmaceutical giant Pfizer sharply scaled back its earnings outlook for the year, blaming lower-than-expected sales of two drugs used to treat COVID-19, the company said Friday.


Posted by Editor

For Spring 2024, Designers Trade Soigné Chic for Workwear Cool

For Spring 2024, Designers Trade Soigné Chic for Workwear Cool

Fitness fans say this vibrating plate helps them 'achieve an hours exercise in fifteen minutes'

Shoppers say this vibrating plate is revolutionising their workouts